• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌治疗对慢性实验大鼠全身炎症反应和抗生素诱导的肠道菌群失调相关血流动力学反应的影响。

Effect of Probiotic Therapy on Hemodynamic Response Associated with Systemic Inflammatory Reaction and Antibiotic-Induced Dysbiosis in Chronic Experiments in Rats.

机构信息

Institute of Experimental Medicine, V. A. Almazov National Medical Research Center, Ministry of the Health of the Russian Federation, St. Petersburg, Russia.

出版信息

Bull Exp Biol Med. 2022 Apr;172(6):676-680. doi: 10.1007/s10517-022-05455-w. Epub 2022 May 2.

DOI:10.1007/s10517-022-05455-w
PMID:35501641
Abstract

The effect of probiotic therapy on the main hemodynamic parameters was studied in Wistar rats with modeled syndrome of systemic inflammatory response resulting from chemically induced colitis complicated by antibiotic-induced dysbiosis. Using a wireless telemetry monitoring system in round-the-clock mode, the mean systolic and diastolic BP, HR, and body temperature were measured over 27 days. In the group of animals receiving no probiotics, a significant decrease in feed consumption and body weight loss were observed. By the end of the experiment, BP in this group was lower by 12% and HR was higher by 10% than in the control. In animals treated with a mixture of probiotic strains Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis, all the studied parameters returned to the initial values. Thus, we demonstrated the possibility of using probiotic drugs for the treatment of acute systemic inflammatory process, which should be considered in the development of new treatment protocols in veterinary and medicine.

摘要

本研究旨在探讨益生菌疗法对全身炎症反应综合征(systemic inflammatory response syndrome, SIRS)模型大鼠主要血流动力学参数的影响。该模型由化学诱导结肠炎合并抗生素诱导的肠道菌群失调引起。采用无线遥测监测系统,在 27 天的时间内对平均收缩压、舒张压、心率(heart rate, HR)和体温进行了昼夜监测。在未接受益生菌治疗的动物组中,观察到饲料摄入量显著减少和体重减轻。实验结束时,该组的血压降低了 12%,心率升高了 10%,与对照组相比。在接受嗜酸乳杆菌和动物双歧杆菌亚种乳酸混合益生菌菌株治疗的动物中,所有研究参数均恢复到初始值。因此,我们证明了使用益生菌药物治疗急性全身炎症过程的可能性,这在兽医和医学新治疗方案的制定中应予以考虑。

相似文献

1
Effect of Probiotic Therapy on Hemodynamic Response Associated with Systemic Inflammatory Reaction and Antibiotic-Induced Dysbiosis in Chronic Experiments in Rats.益生菌治疗对慢性实验大鼠全身炎症反应和抗生素诱导的肠道菌群失调相关血流动力学反应的影响。
Bull Exp Biol Med. 2022 Apr;172(6):676-680. doi: 10.1007/s10517-022-05455-w. Epub 2022 May 2.
2
Safety evaluation of HOWARU Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity.HOWARU Restore(嗜酸乳杆菌NCFM、副干酪乳杆菌Lpc-37、动物双歧杆菌乳亚种Bl-04和乳酸双歧杆菌Bi-07)的抗生素耐药性、基因组风险因素及急性毒性安全性评估。
Food Chem Toxicol. 2017 Dec;110:316-324. doi: 10.1016/j.fct.2017.10.037. Epub 2017 Nov 5.
3
Combination of and subsp. Shows a Stronger Anti-Inflammatory Effect than Individual Strains in HT-29 Cells.和亚种的组合在 HT-29 细胞中比单个菌株表现出更强的抗炎作用。
Nutrients. 2019 Apr 27;11(5):969. doi: 10.3390/nu11050969.
4
Probiotic Therapy with and subsp. Results in Infarct Size Limitation in Rats with Obesity and Chemically Induced Colitis.使用嗜酸乳杆菌和干酪乳杆菌亚种进行益生菌治疗可限制肥胖和化学诱导性结肠炎大鼠的梗死面积。
Microorganisms. 2022 Nov 18;10(11):2293. doi: 10.3390/microorganisms10112293.
5
The effect of probiotic bacteria (Lactobacillus acidophilus and Bifidobacterium lactis) on the accumulation of lead in rat brains.益生菌(嗜酸乳杆菌和双歧杆菌)对大鼠脑组织中铅积累的影响。
Environ Sci Pollut Res Int. 2017 Jan;24(2):1700-1705. doi: 10.1007/s11356-016-7946-9. Epub 2016 Oct 29.
6
The efficacy of a mix of three probiotic strains in reducing abdominal pain and inflammatory biomarkers in acute uncomplicated diverticulitis.三种益生菌菌株混合使用在减少急性单纯性憩室炎腹痛和炎症生物标志物方面的疗效。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):9126-9133. doi: 10.26355/eurrev_201910_19316.
7
Probiotic Bifidobacterium animalis subsp. lactis Bi-07 alleviates bacterial translocation and ameliorates microinflammation in experimental uraemia.益生菌动物双歧杆菌乳酸亚种Bi-07可减轻实验性尿毒症中的细菌移位并改善微炎症。
Nephrology (Carlton). 2014 Aug;19(8):500-6. doi: 10.1111/nep.12272.
8
Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.抗生素/益生菌干预期间摄入的嗜酸乳杆菌LaCH-5和动物双歧杆菌乳亚种Bb-12菌株对四环素的敏感性。
Int J Antimicrob Agents. 2007 Mar;29(3):271-80. doi: 10.1016/j.ijantimicag.2006.09.020. Epub 2007 Jan 5.
9
Benefits of Bifidobacterium animalis subsp. lactis Probiotic in Experimental Periodontitis.动物双歧杆菌亚种乳双歧杆菌益生菌在实验性牙周炎中的益处。
J Periodontol. 2017 Feb;88(2):197-208. doi: 10.1902/jop.2016.160217. Epub 2016 Sep 23.
10
The Administration Matrix Modifies the Beneficial Properties of a Probiotic Mix of Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus acidophilus LA-5.管理矩阵改变了动物双歧杆菌亚种乳双歧杆菌 BB-12 和嗜酸乳杆菌 LA-5 益生菌混合物的有益特性。
Probiotics Antimicrob Proteins. 2021 Apr;13(2):484-494. doi: 10.1007/s12602-020-09702-2.

引用本文的文献

1
Hemodynamic Parameters in Spontaneously Hypertensive Rats with Obesity and Chemically Induced Colitis during Probiotic Therapy.自发性高血压肥胖大鼠与化学诱导结肠炎在益生菌治疗期间的血液动力学参数。
Bull Exp Biol Med. 2024 Mar;176(5):543-547. doi: 10.1007/s10517-024-06064-5. Epub 2024 May 8.
2
The Contribution of the Intestinal Microbiota to the Celiac Disease Pathogenesis along with the Effectiveness of Probiotic Therapy.肠道微生物群对乳糜泻发病机制的贡献以及益生菌疗法的有效性。
Microorganisms. 2023 Nov 23;11(12):2848. doi: 10.3390/microorganisms11122848.
3
The Probiotic Strains Bifidοbacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Saccharomyces boulardii Regulate Wound Healing and Chemokine Responses in Human Intestinal Subepithelial Myofibroblasts.

本文引用的文献

1
Host-microbiota interactions in inflammatory bowel disease.炎症性肠病中的宿主-微生物群相互作用。
Nat Rev Immunol. 2020 Jul;20(7):411-426. doi: 10.1038/s41577-019-0268-7. Epub 2020 Jan 31.
2
Effect of Antiobiotic-Induced Disbiosis and Its Correction with Probiotics on Myocardial Tolerance to Ischemia-Reperfusion Injury in SPF Rats.抗生素诱导的菌群失调及其用益生菌纠正对SPF大鼠心肌缺血再灌注损伤耐受性的影响
Bull Exp Biol Med. 2019 Feb;166(4):440-443. doi: 10.1007/s10517-019-04368-5. Epub 2019 Feb 20.
3
Higher Frequency of Nocturnal Blood Pressure Dipping but Not Heart Rate Dipping in Inflammatory Bowel Disease.
益生菌菌株乳酸双歧杆菌、嗜酸乳杆菌、植物乳杆菌和布拉氏酵母菌可调节人肠上皮下肌成纤维细胞的伤口愈合和趋化因子反应。
Pharmaceuticals (Basel). 2022 Oct 20;15(10):1293. doi: 10.3390/ph15101293.
炎症性肠病患者夜间血压下降频率较高,但心率下降情况并非如此。
Dig Dis Sci. 2017 Oct;62(10):2863-2869. doi: 10.1007/s10620-017-4712-x. Epub 2017 Aug 23.
4
Gut Microbiota in Cardiovascular Health and Disease.肠道微生物群与心血管健康和疾病
Circ Res. 2017 Mar 31;120(7):1183-1196. doi: 10.1161/CIRCRESAHA.117.309715.
5
Can probiotics modulate human disease by impacting intestinal barrier function?益生菌能否通过影响肠道屏障功能来调节人类疾病?
Br J Nutr. 2017 Jan;117(1):93-107. doi: 10.1017/S0007114516004037.
6
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders.功能性肠病中肠道微生物群的治疗性调节
J Neurogastroenterol Motil. 2017 Jan 30;23(1):9-19. doi: 10.5056/jnm16124.
7
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.肠道微生物群在与肥胖相关的低度炎症和 2 型糖尿病发展中的作用。
Gut Microbes. 2012 Jul-Aug;3(4):279-88. doi: 10.4161/gmic.19625. Epub 2012 May 14.
8
Gut microbiome, obesity, and metabolic dysfunction.肠道微生物组、肥胖和代谢功能障碍。
J Clin Invest. 2011 Jun;121(6):2126-32. doi: 10.1172/JCI58109. Epub 2011 Jun 1.
9
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.由葡聚糖硫酸钠(DSS)诱导的慢性实验性结肠炎的特征是Th1和Th2细胞因子。
Clin Exp Immunol. 1998 Dec;114(3):385-91. doi: 10.1046/j.1365-2249.1998.00728.x.